Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liyin Huang
Institution:
Ganzhou People's Hospital
Observed institutions:
Nanchang University,
Ganzhou People's Hospital,
Guangxi University of Chinese Medicine
ORCID:
0000-0002-1960-634X
Observed ORCID:
0000-0002-1960-634X
OpenAlex ID:
A5022963068
Ruangan Lidan decoction inhibits the growth and metastasis of liver cancer by downregulating miR-9-5p and upregulating PDK4
2023
·
Tao Si
, Liyin Huang
, et al.
·
Cancer Biology & Therapy
·
12
PDF
Efficacy Investigation of TACE Combined with Lenvatinib and Sintilimab in Intermediate-Stage Hepatocellular Carcinoma
2022
·
Menglong Zhang
, Weiguo Lai
, et al.
·
Disease Markers
·
6
PDF
miR-302a-3p Promotes Radiotherapy Sensitivity of Hepatocellular Carcinoma by Regulating Cell Cycle via MCL1
2022
·
Zifeng Yang
, Menglong Zhang
, et al.
·
Computational and Mathematical Methods in Medicine
·
5
PDF
Exploring the potential value of SRC in pan cancer based on bioinformatics methods
2025
·
Liyin Huang
, Yanwen Lu
, et al.
·
Discover Oncology
·
4
PDF
CT-MR Image Fusion for Post-Implant Dosimetry Analysis in Brain Tumor Seed Implantation- a Preliminary Study
2022
·
Menglong Zhang
, Cunkun Chu
, et al.
·
Disease Markers
·
4
PDF
The efficacy and safety of 125I brachytherapy combined with pre-operative transarterial chemoembolization in patients with locally advanced head and neck cancer
2022
·
Menglong Zhang
, Jian Zhang
, et al.
·
Frontiers in Oncology
·
2
PDF
Early-stage HER2-positive breast cancer in neurofibromatosis type 1: a case report with literature review
2026
·
Fulan Yang
, Sujuan Dai
, et al.
·
Frontiers in Oncology
PDF
Exploring the potential anti-hepatocarcinoma mechanism of Ruangan Lidan Decoction through UHPLC-Q-TOF-MS/MS analysis and network pharmacology approaches
2025
·
Liyin Huang
, Tao Si
, et al.
·
Current Pharmaceutical Analysis
Show more works
View as search
Works count:
8
Citation count:
33
H-index:
4
I10-index:
1
Year
Topic
Type